A large-scale randomized trial found no difference in the number of hypertension events reported in those using tocilizumab compared to placebo.43,44 Thus, the acute responses to pharmacological doses of Ang II in the mouse model may not faithfully reproduce the human setting of AAA. The gene discussed is AGT; the disease is triple-A syndrome.